The Most Prominent Manifestations of Illness in COVID-19 Patients and Their Relationship to the Severity of Disease and Mortality in one of Isolation and Intensive Care Centers in North Western of Libya
DOI:
https://doi.org/10.63318/waujpasv4i1_30Keywords:
COVID-19, D-dimer, CRP, Diabetes, High blood pressure, LibyaAbstract
As SARS-CoV-2 spread rapidly across continents giving rise to the COVID-19 pandemic; scientists have worked intensively to understand the virus built, behavior and Response to vaccination and treatment. This descriptive-analytical study aimed: to assess the impact of predisposing risk factors, specifically age and chronic diseases, on predicting the extent of health deterioration and increased likelihood of mortality in COVID-19 patients. Methods: In this study, data from 100 treated patients were examined at one of Isolation and Intensive Care Centers in north western of Libya “Surman “.data were extracted from medical records using a data collection form, and patients were classified according to the WHO's clinical assessment criteria, reported risk factors and laboratory indicators. Most patients were men 66% with an average age of 68 years. Common conditions included diabetes 34%, hypertension 28%, and other comorbidities 24%. 11% of cases were classified as mild, 40% as moderate, and nearly 49% as severe. Significantly, many patients 89%, required intensive care with a survival rate of 69% and a mortality rate of 31%. Results: Disease severity was significantly associated with specific biomarker profiles at admission, characterized by decreased oxygen saturation 85.47% and elevated levels of CRP (118.5 mg/L) and D-dimer (1.86 µg/mL). Moreover, CRP and D-dimer levels showed a direct positive correlation with infection severity. Recommendations: the need to strengthen community compliance with preventive measures and activate early medical intervention mechanisms as soon as clinical symptoms appear to reduce the risk of morbidity.
Downloads
Downloads
Published
Issue
Section
License
Copyright (c) 2026 The authors

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
This journal uses Creative Commons Attribution-Noncommerical 4.0 International License (CC BY-NC 4.0), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. To view a copy of this license, visit https://creativecommons.org/licenses/by-nc/4.0/.
Copyright of articles
Authors retain copyright of their articles published in this journal.
